• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从甲状腺自主功能性腺瘤中分离出的促甲状腺激素受体突变赋予甲状腺细胞不依赖促甲状腺激素的生长特性。

Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.

作者信息

Porcellini A, Ruggiano G, Pannain S, Ciullo I, Amabile G, Fenzi G, Avvedimento E V

机构信息

Istituto Nazionale dei Tumori, Fondazione G Pascale, Napoli & Dipartimento di Biologia e Patologia Molecolare e Cellulare L Califano, Facoltà di Medicina, Università Federico II, Italy.

出版信息

Oncogene. 1997 Aug 14;15(7):781-9. doi: 10.1038/sj.onc.1201240.

DOI:10.1038/sj.onc.1201240
PMID:9266964
Abstract

TSH receptor mutants in the VI transmembrane segment, found in thyroid autonomously functioning adeonomas, have been expressed in differentiated thyroid cells. All mutant receptors constitutively stimulated adenylyl cyclase. The biological activity, measured as cAMP production relative to the wild type receptor, was specific for each mutant in transient and stable transfection assays. Cells expressing these mutants proliferated in the absence of TSH. The rate of growth in the absence of TSH paralleled basal cAMP production for each mutant receptor. Low TSH concentrations stimulated the growth of mutant receptor-expressing cells, and not of the cells expressing the wild type receptor. Also, the entry in the cell cycle and the plating efficiency were markedly stimulated by the expression of the mutant receptors. These data provide a molecular link between the occurrence of TSH receptor mutations and thyroid autonomously functioning adenomas.

摘要

在甲状腺自主功能性腺瘤中发现的位于VI跨膜段的促甲状腺激素(TSH)受体突变体,已在分化型甲状腺细胞中表达。所有突变体受体均组成性地刺激腺苷酸环化酶。在瞬时和稳定转染实验中,以相对于野生型受体的环磷酸腺苷(cAMP)产生量来衡量的生物活性,对每个突变体都是特异性的。表达这些突变体的细胞在无TSH的情况下增殖。在无TSH时的生长速率与每个突变体受体的基础cAMP产生量平行。低浓度TSH刺激表达突变体受体的细胞生长,而不刺激表达野生型受体的细胞生长。此外,突变体受体的表达显著刺激细胞周期进入和接种效率。这些数据提供了TSH受体突变的发生与甲状腺自主功能性腺瘤之间的分子联系。

相似文献

1
Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.从甲状腺自主功能性腺瘤中分离出的促甲状腺激素受体突变赋予甲状腺细胞不依赖促甲状腺激素的生长特性。
Oncogene. 1997 Aug 14;15(7):781-9. doi: 10.1038/sj.onc.1201240.
2
Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas.促甲状腺激素受体VI跨膜段的体细胞突变在甲状腺功能亢进性腺瘤中组成性激活cAMP信号传导。
Oncogene. 1995 Sep 21;11(6):1089-93.
3
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.促甲状腺激素受体基因的体细胞突变会导致甲状腺功能亢进性腺瘤。
Nature. 1993 Oct 14;365(6447):649-51. doi: 10.1038/365649a0.
4
Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.毒性甲状腺滤泡性腺瘤中两个新型促甲状腺激素受体激活突变体的鉴定与功能表征
Thyroid. 2009 Jun;19(6):645-9. doi: 10.1089/thy.2009.0002.
5
Enhanced functional activity in thyroid adenomas in vitro.甲状腺腺瘤体外功能活性增强。
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:39-40. doi: 10.1055/s-0029-1211699.
6
Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.人促甲状腺激素受体在缺乏内源性促甲状腺激素受体的人甲状腺癌细胞系中的表达:环磷酸腺苷介导的生长抑制作用
Biochem Biophys Res Commun. 1993 Mar 31;191(3):1131-8. doi: 10.1006/bbrc.1993.1334.
7
Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.人类甲状腺细胞和自主性腺瘤中的基因表达揭示了肿瘤发生过程中负反馈的抑制。
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):413-8. doi: 10.1073/pnas.0507354102. Epub 2005 Dec 28.
8
Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells.在FRTL-5细胞中表达的突变型人促甲状腺激素受体的致癌潜能。
Oncogene. 1998 Feb 26;16(8):985-90. doi: 10.1038/sj.onc.1201626.
9
Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.组成性激活促甲状腺激素受体突变作为毒性甲状腺腺瘤、多结节毒性甲状腺肿和常染色体显性非自身免疫性甲状腺功能亢进症的病因。
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:129-32. doi: 10.1055/s-0029-1211720.
10
Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.毒性多结节性甲状腺肿中的高功能甲状腺结节与孤立性毒性腺瘤一样,都存在激活促甲状腺激素受体突变。
J Clin Endocrinol Metab. 1998 Feb;83(2):492-8. doi: 10.1210/jcem.83.2.4559.

引用本文的文献

1
Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.控制和甲状腺相关眼病(TAO)眼眶脂肪及发生脂肪生成的 TAO 眼眶成纤维细胞的转录组特征分析。
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):24. doi: 10.1167/iovs.62.9.24.
2
Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.G蛋白偶联受体的组成性激活与疾病:激活机制及治疗学见解
Pharmacol Ther. 2008 Nov;120(2):129-48. doi: 10.1016/j.pharmthera.2008.07.005. Epub 2008 Aug 9.
3
Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis.
甲状腺调节与甲状腺癌发生机制研究的最新进展
Environ Health Perspect. 1998 Aug;106(8):427-36. doi: 10.1289/ehp.106-1533202.